Medtronic Moves Closer To Closed-Loop Diabetes Care With Paradigm

Earlier-than-anticipated approval of its Paradigm real-time insulin pump and continuous glucose monitoring system again puts Medtronic one step ahead of the competition in moving toward "closed-loop" diabetes management, the company suggests

More from Archive

More from Medtech Insight